We observed that the frequency of this cell population within CD8+ T cells was higher in patients with AML and CMML than in those with LR-MDS and HR-MDS (Fig. 2F), which is consistent with the findings from the unsupervised analysis of data derived from CyTOF. The gene discussed is CD8A; the disease is acute myeloid leukemia.